Morgan Stanley vs Nomura
MS and NMR side by side, both in security brokers, dealers, and flotation. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MS and NMR compare
Morgan Stanley grew revenue faster over the last twelve months (18.0% versus 0.46% for Nomura).
Morgan Stanley keeps more of each dollar of sales as profit, with a net margin of 25.8% compared with 7.6% at Nomura.
Morgan Stanley pays a dividend yielding 2.3%; Nomura does not pay one.
Morgan Stanley scores higher on the StockData Score (17 against 5 for Nomura), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MS | NMR |
|---|---|---|
| Size and price | ||
| Market cap | $289B | – |
| Share price | $184.30 | $9.38 |
| Change, 1 year | 12.4% | 32.7% |
| Change, 5 years | 84.5% | 109% |
| Beta (5Y) | 1.20 | 0.96 |
| Employees | 83K | – |
| StockData Score | ||
| Total score | 17 (better) | 5 |
| Valuation score | 4 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 4 (better) | 2 |
| Health score | 4 (better) | 1 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 14.9× | – |
| P/S | 3.7× | – |
| P/B | 2.5× | – |
| PEG | 0.81 | – |
| Fair value | $190.74 | – |
| Margin of safety | 3.4% | – |
| Growth | ||
| Revenue growth (TTM) | 18.0% (better) | 0.46% |
| Revenue growth, 5Y average | 7.7% | 24.1% (better) |
| Net income growth (TTM) | 36.6% (better) | 6.3% |
| EPS growth (TTM) | 40.1% (better) | 7.2% |
| EPS growth, 5Y average | 9.6% | 19.6% (better) |
| Profitability | ||
| Net margin | 25.8% (better) | 7.6% |
| FCF margin | – | −25.2% |
| Return on equity | 18.0% (better) | 10.1% |
| Financial health | ||
| Debt / equity | 0.00 | 0.47 (better) |
| Net debt / EBITDA | – | −0.80 |
| Altman Z-score | 0.26 | – |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 2.3% | – |
| Payout ratio | 33.6% | 49.6% |
| Years of dividend growth | 12 | – |
| Dividend growth, 5Y average | 22.4% | – |
| Shareholder yield | 2.3% | – |
| Ownership | ||
| Held by institutions | 85.9% | 3.0% |
| Held by insiders | 24.4% | 0.12% |
| Insider net buying, 12 months | −$51.7M | $3.9K (better) |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 1.2% | – |
Go deeper
- MS stock overview
- MS income statement
- MS valuation and score
- NMR stock overview
- NMR income statement
- NMR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.